DXSE.DE vs. CURE.DE
DXSE.DE (Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C) and CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) are both Health & Biotech Equities funds - DXSE.DE tracks the MSCI Europe Health Care ESG Screened 20-35 while CURE.DE tracks the MVIS Global Future Healthcare ESG. Both are passively managed. Over the past 3 years, DXSE.DE returned 2.51%/yr vs -2.48%/yr for CURE.DE. At a 0.38 correlation, their price movements are largely independent. DXSE.DE charges 0.17%/yr vs 0.35%/yr for CURE.DE.
Performance
DXSE.DE vs. CURE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DXSE.DE achieves a -1.95% return, which is significantly higher than CURE.DE's -5.10% return.
DXSE.DE
- 1D
- 2.90%
- 1M
- 0.52%
- YTD
- -1.95%
- 6M
- -0.32%
- 1Y
- 5.13%
- 3Y*
- 2.51%
- 5Y*
- 5.38%
- 10Y*
- 6.10%
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
DXSE.DE vs. CURE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
DXSE.DE Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C | -1.95% | 4.97% | 4.52% | 9.56% | 2.03% |
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
Correlation
The correlation between DXSE.DE and CURE.DE is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.48 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.38 |
The correlation between DXSE.DE and CURE.DE shifts across timeframes, from 0.38 (3 years) to 0.48 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DXSE.DE vs. CURE.DE — Risk / Return Rank
DXSE.DE
CURE.DE
DXSE.DE vs. CURE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DXSE.DE | CURE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.02 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.06 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | 0.30 | +0.07 |
| Martin ratioReturn relative to average drawdown | 0.82 | 0.68 | +0.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DXSE.DE | CURE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.27 | 0.29 | -0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | -0.14 | +0.58 |
Drawdowns
DXSE.DE vs. CURE.DE - Drawdown Comparison
The maximum DXSE.DE drawdown since its inception was -34.30%, roughly equal to the maximum CURE.DE drawdown of -34.80%. Use the drawdown chart below to compare losses from any high point for DXSE.DE and CURE.DE.
Loading charts...
Drawdown Indicators
| DXSE.DE | CURE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.30% | -34.80% | +0.50% |
Max Drawdown (1Y)Largest decline over 1 year | -12.67% | -19.07% | +6.40% |
Max Drawdown (3Y)Largest decline over 3 years | -28.10% | -29.32% | +1.22% |
Max Drawdown (5Y)Largest decline over 5 years | -28.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -28.10% | — | — |
Current DrawdownCurrent decline from peak | -13.88% | -15.66% | +1.78% |
Average DrawdownAverage peak-to-trough decline | -8.34% | -15.12% | +6.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.81% | 8.53% | -2.72% |
Volatility
DXSE.DE vs. CURE.DE - Volatility Comparison
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) have volatilities of 5.82% and 5.73%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DXSE.DE | CURE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.82% | 5.73% | +0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 11.95% | 15.20% | -3.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.63% | 19.97% | -2.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.48% | 20.74% | -4.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.04% | 20.74% | -4.70% |
DXSE.DE vs. CURE.DE - Expense Ratio Comparison
DXSE.DE has a 0.17% expense ratio, which is lower than CURE.DE's 0.35% expense ratio.
Dividends
DXSE.DE vs. CURE.DE - Dividend Comparison
Neither DXSE.DE nor CURE.DE has paid dividends to shareholders.
Frequently Asked Questions
DXSE.DE and CURE.DE have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DXSE.DE is cheaper at 0.17% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DXSE.DE is cheaper with a 0.17% expense ratio, compared with 0.35% for CURE.DE.
DXSE.DE tracks MSCI Europe Health Care ESG Screened 20-35, while CURE.DE tracks MVIS Global Future Healthcare ESG. They also come from different issuers: Xtrackers and VanEck. Their fees differ too: 0.17% for DXSE.DE and 0.35% for CURE.DE.
Find the right allocation for DXSE.DE and CURE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer